Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
POU domain class 5 transcription factor 1 (POU5F1) mRNA, commonly known as OCT4 mRNA, encodes a master transcription factor that is essential for the maintenance of pluripotency and self-renewal in embryonic stem cells and primordial germ cells (UniProt, 1.2.2; GeneCards, 1.2.2). While its expression is typically silenced in adult somatic tissues, it is frequently reactivated in various malignancies, particularly in cancer stem cell (CSC) populations, where it drives tumor progression, chemoresistance, and metastasis (NIH, 1.3.2; AACR, 1.3.4). As a therapeutic target, POU5F1 mRNA is being actively explored using RNA-based strategies such as small interfering RNAs (siRNAs) and antisense oligonucleotides (ASOs) to downregulate OCT4 protein levels and induce differentiation or apoptosis in cancer cells (Ant Bio, 1.3.1; Drug Discovery News, 1.1.1). Targeting the mRNA transcript provides a strategic advantage over direct protein inhibition, as the OCT4 protein lacks traditional small-molecule binding pockets. However, therapeutic development faces challenges related to the precise delivery of RNA molecules and the potential for adverse effects on endogenous stem cell populations required for tissue homeostasis (NIH, 1.4.3; News-Medical, 1.4.4).
RNA interference (siRNA) or antisense-mediated degradation (ASO) of the mRNA transcript to prevent translation of the OCT4 protein.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on POU domain class 5 transcription factor 1 mRNA (POU5F1 mRNA) (POU5F1 mRNA).